Manufacturing continued to be the main source of wealth in India with 17 per cent of the rich list, followed by pharmaceuticals and real estate, which have both seen their percentages drop slightly to 11 per cent and nine per cent, down from 12 per cent and 10 per cent respectively.

Pharmaceutical sector accounted for 11 per cent of super rich Indians, only second to manufacturing sector while Dilip Shanghvi of Sun Pharmaceuticals broke into the top three among the wealthiest Indians, according the Hurun India Rich List.

According to the rich list, prepared by the China-based Hurun Report Inc, Dilip Shanghvi (58) has a personal wealth of $14,100 million. The founder of Sun Pharmaceuticals, India’s second largest drug maker, broke into the top 3 for the first time with a 66 per cent surge in his wealth. This rise in stock price was supported by the expected sales of the cancer drug Doxil, following Janssen Pharma Inc’s admission of shortage of the drug supply.

Manufacturing continued to be the main source of wealth in India with 17 per cent of the rich list, followed by pharmaceuticals and real estate, which have both seen their percentages drop slightly to 11 per cent and nine per cent, down from 12 per cent and 10 per cent respectively.

The list has found 141 individuals with US$ 300m or more, up 41 from last year. Despite a wealth decrease of two per cent, energy tycoon Mukesh Ambani (56) with a personal asset of $18.9 billion topped the list. London-based L N Mittal (63), the steel tycoon retained number two position with an asset of $15.9 billion, according to the second edition of the Hurun India rich list.

Kiran Mazumdar-Shaw (Biocon) came third among the richest Indian women. Desh Bandhu Gupta of Lupin Pharmaceuticals with a net worth of $3,400 million registered 36 per cent growth in his assets over the year to stand 17 in the list. Likewise, Cyrus Poonawalla of Serum Pharma came 23rd with $2,600 million assets, after recording a growth of 13 per cent.

Yusuf Hamied of Cipla Pharmaceuticals ($2,200 million) (26 rank), Pankaj Patel ($1,900 million) of Cadila Healthcare (rank 29), GV Prasad ($1,900 million) of Dr Reddy’s Lab (rank 29), Ajay Piramal ($500 million) of Piramal Healthcare (rank 40), Sudhir & Samir Mehta ($1,400 million) of Torrent Pharma (rank 43), Murali Divi ($1,200 million) of Divi’s Lab (rank 50), Glenn Saldanha & Family ($1,200 million) of Glenmark Pharma (rank 50), Premchand Godha ($700 million) of IPCA Laboratories (rank 80), PV Ramaprasad Reddy ($600 million) of Aurobindo Pharma (rank 96), Hasmukh Chudgar & Family ($500 million) of Intas Pharma (rank 106), Chirayu R Amin ($400 million) of Alembic Pharma (rank 107), and Mannalal B Agarwal Family ($300 million) of Ajanta Pharma (127) are among the super rich Indians.

From the healthcare sector, Prathap Reddy ($800 million) of Apollo Hospitals with a rank of 77, Habil Khorakiwala ($700 million) of Wockhardt with ranking of 85 and Dubai-based Azad Moopen ($400 million) of DM Healthcare with ranking of 114 are in the rich list.